HTR1A downregulation simultaneously activates these two pathways, thereby playing a key role in tumorigenesis and cancer development.[48] The Model of the mechanism of HTR1A in triple‐negative breast cancer was shown in Figure 6k. This evidence concerns the gene HTR1A and cancer.